logo
  • About Initiator Pharma
    • Mission
    • Scientific and Clinical Advisory Board
    • Goals, strategy and business model
    • CEO Letter
    • History
  • Science
    • Pipeline
    • Pudafensine
      • Clinical programs
        • IPED2015 – Organic Erectile dysfunction
        • IPTN2021 – Neuropathic Pain
      • Preclinical program
        • IPFSD2023 – Female Sexual Dysfunction
    • IP2018
      • Clinical programs
        • IP2018 – Psychogenic Erectile dysfunction
      • Preclinical program
        • IPFSD2023 – Female Sexual Dysfunction
    • Therapeutic Areas
      • Erectile Dysfunction
      • Female Sexual Dysfunction
      • Depression
      • Trigeminal Neuralgia
  • Governance
    • General Meetings
    • Management
    • Board of Directors
    • Auditing
    • Articles of Association
    • Remuneration and incentive program
  • Investors
    • Investment case
    • Financial Reports
    • The Share
    • Ownership Structure
    • Analyst and Media Coverage
    • Financial Calendar
    • Prospectuses
    • Press Releases
    • Subscribe
    • Certified Adviser
  • Media
    • Press Releases
    • Event Calendar
    • Subscribe
  • Contact
Loading..

Rights Issue 2025

June 10, 2025

Documents

  • Memorandum
    June 10, 2025 English
    Download pdf
  • Disclosure Document In Accordance With Annex IX
    June 10, 2025 English
    Download pdf
  • Press release – Initiator Pharma offentliggör memorandum och informationsdokument avseende Företrädesemissionen
    June 10, 2025 Svenska
    Download pdf
  • Investors
    • Investment case
    • Financial Reports
    • The Share
    • Ownership Structure
    • Analyst and Media Coverage
    • Financial Calendar
    • Prospectuses
    • Press Releases
    • Subscribe
    • Certified Adviser
Initiator Pharma logo
About Initiator Pharma
  • Mission
  • Scientific and Clinical Advisory Board
  • Goals, strategy and business model
  • CEO Letter
  • History
Science
  • Pipeline
  • Pudafensine
    • Clinical programs
    • Preclinical program
  • IP2018
    • Clinical programs
    • Preclinical program
  • Therapeutic Areas
    • Erectile Dysfunction
    • Female Sexual Dysfunction
    • Depression
    • Trigeminal Neuralgia
Governance
  • General Meetings
  • Management
  • Board of Directors
  • Auditing
  • Articles of Association
  • Remuneration and incentive program
Investors
  • Investment case
  • Financial Reports
  • The Share
  • Ownership Structure
  • Analyst and Media Coverage
  • Financial Calendar
  • Prospectuses
  • Press Releases
  • Subscribe
  • Certified Adviser
Media
  • Press Releases
  • Event Calendar
  • Subscribe
Contact
Edit

Share

Read more
  • Cookies
  • Privacy